Hiroshi Sogawa, MD, MBA, CPE, FACS
Surgical Director of Liver Transplantation, Transplant & Immunology SurgeryCards
Contact Info
Training
Mount Sinai Medical Center/Icahn School of Medicine (2008)
SUNY Stony Brook (Stony Brook University) Hospital (2006)
Massachusetts General Hospital/Harvard Medical School (2000)
Education
Boston University, Questrom School of Business (2025)
Shiga University of Medical Science, School of Medicine (1995)
Contact Info
Training
Mount Sinai Medical Center/Icahn School of Medicine (2008)
SUNY Stony Brook (Stony Brook University) Hospital (2006)
Massachusetts General Hospital/Harvard Medical School (2000)
Education
Boston University, Questrom School of Business (2025)
Shiga University of Medical Science, School of Medicine (1995)
Contact Info
Training
Mount Sinai Medical Center/Icahn School of Medicine (2008)
SUNY Stony Brook (Stony Brook University) Hospital (2006)
Massachusetts General Hospital/Harvard Medical School (2000)
Education
Boston University, Questrom School of Business (2025)
Shiga University of Medical Science, School of Medicine (1995)
About
Copy Link
Titles
Surgical Director of Liver Transplantation, Transplant & Immunology Surgery
Biography
Hiroshi Sogawa, MD, MBA, CPE, FACS is Professor of Surgery (Pending) at Yale School of Medicine and Surgical Director of the Liver Transplant Program at Yale School of Medicine and Yale New Haven Hospital.
Dr. Sogawa is a highly accomplished abdominal transplant and hepatobiliary surgeon with over two decades of clinical, academic, and leadership experience in transplantation and hepatobiliary surgery. He is widely recognized for his expertise in liver, intestine, multivisceral, kidney, and pancreas transplantation, with particular distinction in living donor liver transplantation, multi-organ transplantation, and minimally invasive hepatobiliary surgery. His practice reflects a deep commitment to expanding access to life-saving transplantation while ensuring the highest standards of safety, innovation, and patient-centered care.
Prior to joining Yale, Dr. Sogawa served as Professor of Surgery at New York Medical College and Associate Director of Liver Transplantation at Westchester Medical Center, where he also held leadership roles as Vice Chair of Education, Surgical Clerkship Director, and Associate Program Director of the General Surgery Residency Program. Under his leadership, the liver transplant program at Westchester saw significant growth and modernization, with improved outcomes and an enhanced culture of collaboration among surgical, medical, and support teams.
Earlier in his career, Dr. Sogawa was a key member of the transplant team at the University of Pittsburgh Medical Center, one of the largest and most prestigious organ transplant programs in the United States, where he contributed to the program’s continued excellence and national prominence. He completed his clinical fellowship in multi-organ transplant and hepatobiliary surgery at Mount Sinai Medical Center in New York, remaining on faculty there early in his career. In addition, he completed a research fellowship at Massachusetts General Hospital and Harvard Medical School, focusing on transplant immunology and immune tolerance — work that continues to inform his interest in innovative approaches to immunosuppression and graft survival.
Dr. Sogawa’s leadership philosophy emphasizes teamwork, mentorship, and continuous improvement. He has been instrumental in advancing the use of novel technologies, such as machine perfusion for organ preservation and minimally invasive techniques for donor and recipient surgery. He is passionate about fostering a culture of excellence and empathy, mentoring the next generation of surgeons, and building inclusive, high-performing teams.
An active member of national and international transplant societies, Dr. Sogawa has delivered numerous invited lectures and contributed to peer-reviewed research advancing the field of transplantation. He also holds an MBA from Boston University’s Questrom School of Business, and a CPE (Certified Physician Executive) designation from American Association for Physician Leadership, further enriching his ability to lead complex clinical programs with strategic vision and operational excellence.
At Yale, Dr. Sogawa is dedicated to growing and strengthening the liver transplant program to serve more patients across the region, expanding access to living donor transplantation, developing a robust transplant oncology service, and integrating cutting-edge research and innovation to improve outcomes and quality of life for transplant recipients.
Departments & Organizations
- Surgery
- Transplant & Immunology Surgery
- Yale Medicine
Education & Training
- MBA
- Boston University, Questrom School of Business (2025)
- Multi-organ Transplant and Hepatobiliry Surgery Fellow
- Mount Sinai Medical Center/Icahn School of Medicine (2008)
- Surgery resident
- SUNY Stony Brook (Stony Brook University) Hospital (2006)
- Research fellow
- Massachusetts General Hospital/Harvard Medical School (2000)
- Surgery resident
- Tokyo Women's Medical University Hospital (1998)
- Senior intern
- US Naval Hospital Okinawa (1996)
- MD
- Shiga University of Medical Science, School of Medicine (1995)
Advanced Training & Certifications
- Certified Physician Executive
- The American Association for Physician Leadership (AAPL)
- Certified Abdominal Transplant Surgeon
- Transplant Accreditation & Certification Council (TACC) / American Society of Transplant Surgeons (ASTS) (2024)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0003-3724-9005
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
David Mulligan, MD, FACS, FAST, FAASLD
Liver Transplantation
Organ Transplantation
Carcinoma, Hepatocellular
Immune Tolerance
Publications
2025
Development of a HIPAA Compliant Cloud-Based Donor Liver Biopsy Steatosis Assessment Tool Using Artificial Intelligence Technology
Okumura K, Misawa R, Wilson A, Jaramillo N, Dhand A, Sogawa H, Aloman C, Nishida S. Development of a HIPAA Compliant Cloud-Based Donor Liver Biopsy Steatosis Assessment Tool Using Artificial Intelligence Technology. American Journal Of Transplantation 2025, 25: s69-s70. DOI: 10.1016/j.ajt.2025.07.135.Peer-Reviewed Original ResearchCitationsEnhancing Medical Student Exposure to the Field of Transplantation: Assessing Learning Outcomes of a Novel Transplant Education Program in a U.S. Medical School
Beber S, Ekelmans A, Whiteson H, Misawa R, Okumura K, Veillette G, Nishida S, Lansman S, Sogawa H. Enhancing Medical Student Exposure to the Field of Transplantation: Assessing Learning Outcomes of a Novel Transplant Education Program in a U.S. Medical School. American Journal Of Transplantation 2025, 25: s996. DOI: 10.1016/j.ajt.2025.07.2370.Peer-Reviewed Original ResearchLiver transplant practices in the era of normothermic machine perfusion in the United States
Okumura K, Dhand A, Hasjim B, Misawa R, Sogawa H, Veillette G, Nishida S. Liver transplant practices in the era of normothermic machine perfusion in the United States. World Journal Of Transplantation 2025, 15: 100427. PMID: 40535506, PMCID: PMC11886287, DOI: 10.5500/wjt.v15.i2.100427.Peer-Reviewed Original ResearchCitationsConceptsLiver transplantationLong preservation timeSurvival outcomesPost-transplant survival outcomesUnited StatesOlder recipient ageTime of surgeryMachine perfusionLiver machine perfusionPost-transplant survivalPreservation timeShort preservation timeUtilization of donorsLT recipientsNormothermic machine perfusionRecipient ageLiver allograftsSubgroup analysisDCD organsTransplant practiceAllograftRecipientsSurvivalReperfusionCirculatory deathThe effect of Cytomegalovirus seropositivity and recipient age on overall and allograft survival in liver transplant recipients
Lee I, Wilson A, Hanna K, Misawa R, Sogawa H, Veillette G, Nishida S, Dhand A, Okumura K. The effect of Cytomegalovirus seropositivity and recipient age on overall and allograft survival in liver transplant recipients. American Journal Of Transplantation 2025, 25: s118-s119. DOI: 10.1016/j.ajt.2024.12.233.Peer-Reviewed Original ResearchNationwide Analysis of Failure to Rescue Following Liver Transplantation
Hanna K, Lee I, Wilson A, Gogna S, Nishida S, Sogawa H, Misawa R, Veillette G, Okumura K. Nationwide Analysis of Failure to Rescue Following Liver Transplantation. American Journal Of Transplantation 2025, 25: s113. DOI: 10.1016/j.ajt.2024.12.223.Peer-Reviewed Original ResearchA Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report
Patil J, Sogawa H, Mulligan D. A Rare Case of Cyberlindnera jadinii Fungemia in a Kidney Transplant Recipient: A Case Report. Case Reports In Transplantation 2025, 2025: 3478928. PMID: 40936675, PMCID: PMC12422839, DOI: 10.1155/crit/3478928.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsTransplant recipientsRare caseSolid organ transplant recipientsAspergillus speciesOrgan transplant recipientsAntifungal prophylaxisFungal infectionsCausative agentGraft rejectionPerioperative mortalityCase reportKidney transplantationCardiovascular eventsFungemiaEarly diagnosisQuality of lifeSpeciesKidneyImmunosuppressive pathologyMortalityRecipientsInfectionCandidaAspergillus
2024
442.8: Selective BCL-2 inhibition to promote hematopoietic mixed chimerism and renal allograft tolerance in low-dose cyclophosphamide-based conditioning regimen without myelosuppression.
Tomosugi T, Karadagi A, Otsuka R, Tomofuji K, Rosales I, Sogawa H, Cosimi A, Kawai T. 442.8: Selective BCL-2 inhibition to promote hematopoietic mixed chimerism and renal allograft tolerance in low-dose cyclophosphamide-based conditioning regimen without myelosuppression. Transplantation 2024, 108 DOI: 10.1097/01.tp.0001066516.06318.28.Peer-Reviewed Original Research223.4: The outcomes of simultaneous liver–kidney transplantations with a positive crossmatch during safety net policy era in the United States.
Okumura K, Misawa R, Dhand A, Sogawa H, Veillette G, Nishida S. 223.4: The outcomes of simultaneous liver–kidney transplantations with a positive crossmatch during safety net policy era in the United States. Transplantation 2024, 108 DOI: 10.1097/01.tp.0001064372.45422.3f.Peer-Reviewed Original ResearchConceptsNormothermic Machine Perfusion Is Associated With Improvement in Mortality and Graft Failure in Donation After Cardiac Death Liver Transplant Recipients in the United States
Okumura K, Dhand A, Misawa R, Sogawa H, Veillette G, Nishida S. Normothermic Machine Perfusion Is Associated With Improvement in Mortality and Graft Failure in Donation After Cardiac Death Liver Transplant Recipients in the United States. Transplantation Direct 2024, 10: e1679. PMID: 38988687, PMCID: PMC11230788, DOI: 10.1097/txd.0000000000001679.Peer-Reviewed Original ResearchCitationsAltmetricConceptsNormothermic machine perfusion groupNormothermic machine perfusionLiver transplantationLT recipientsGraft survivalPropensity score matchingOverall survivalGraft failureDCD LT recipientsTwo-year overall survivalEnd-stage liver disease scoreMultivariate Cox regression analysisAdult LT recipientsScore matchingLiver transplant recipientsLiver Disease scoreCox regression analysisMachine perfusionUnited Network for Organ SharingUtilization of donationPosttransplant patientsTransplant recipientsAssociated with improvementsNon-MPSOlder donorsPotential Association of Blood Transfusion in Deceased Donors With Outcomes of Liver Transplantation in the United States
Okumura K, Dhand A, Misawa R, Sogawa H, Veillette G, Nishida S. Potential Association of Blood Transfusion in Deceased Donors With Outcomes of Liver Transplantation in the United States. Journal Of Surgical Research 2024, 300: 477-484. PMID: 38875946, DOI: 10.1016/j.jss.2024.05.025.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsDonor blood transfusionIncreased risk of rejectionMultivariate Cox hazard modelOutcome of liver transplantationBlood transfusionRisk of rejectionLiver transplantationCox hazard modelLT recipientsTransfusion donorIncreased riskAssociation of blood transfusionUnited Network for Organ Sharing databaseBlood transfusion donorsRecipients of LTKaplan-Meier methodPost-transplant graftOverall immune suppressionBrain death donorsNo transfusionsOverall survivalPost-LTImmune suppressionGraft failureAdult recipients
Academic Achievements & Community Involvement
Copy Link
Activities
activity New England Organ Bank Clinical Advisory Board
2025 - PresentAdvisory BoardsBoard MemberDetailsNew England Donor Services
Clinical Care
Copy Link
Overview
Clinical Specialties
Board Certifications
Surgery General
- Certification Organization
- AB of Surgery
- Original Certification Date
- 2007
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Copy Link
Get In Touch
Copy Link
Contacts
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Social Media